Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation

Clinical trial NCT02163824 · COMPLETED

Trial details

NCT number: NCT02163824
Sponsor: Kala Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ocular Infections, Irritations and Inflammations

Start date: 2014-05-01
Primary completion: 2014-12-01
Enrollment: 380

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.